Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for prevention of induced coronary vasospasm
2006-003116-22Phase 3Active
- Sponsor
- Robert-Bosch-Krankenhaus
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of sildenafil in Coronary vasospasm (CAS), sponsored by Robert-Bosch-Krankenhaus. Primary endpoint: Inhibition of acetylcholine-induced coronary spasm. Started Jan 2007; status: active.
02
Drugs
sildenafil
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on 2006-003116-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003116-22.